Page last updated: 2024-10-31

neostigmine and Milk-Alkali Syndrome

neostigmine has been researched along with Milk-Alkali Syndrome in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Panettiere, FJ1
Lick, RF1
Endriss, R1
Hart, W1
Balser, D1

Reviews

1 review available for neostigmine and Milk-Alkali Syndrome

ArticleYear
The current management of malignancy. IV.-Cancer of the lung.
    Alaska medicine, 1975, Volume: 17, Issue:3

    Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, S

1975

Other Studies

1 other study available for neostigmine and Milk-Alkali Syndrome

ArticleYear
[Influence of hypercalcemia on the simultaneously stimulated secretion in the vagus innervated main stomach and the vagus denervated Heidenhain pouch].
    Medizinische Klinik, 1967, Aug-18, Volume: 62, Issue:33

    Topics: Animal Feed; Animals; Calcium; Denervation; Dogs; Female; Gastric Juice; Gastrins; Glucose; Histamin

1967